New York, United States, July 20, 2022 (GLOBE NEWSWIRE) — The global TB diagnostics market had a market share of USD 1,337.30 million in 2021, according to the new report of Straits Research. It is predicted to grow at a CAGR of 5.56% from 2022 to 2030. The global TB diagnostics market is expected to grow due to the rising prevalence of tuberculosis and the preponderance of multidrug-resistant tuberculosis infection.
Mycobacterium tuberculosis is the bacteria that causes tuberculosis. Despite being treated, it remains one of the significant causes of death in adults, particularly in underdeveloped countries. According to the World Health Organization (WHO), tuberculosis affects about a quarter of the world’s population. In addition, tuberculosis-infected people have a 5% to 10% probability of being very unwell.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/tb-diagnostics-market/request-sample
People with compromised immune systems, such as HIV, malnutrition, diabetes, or smokers, are more prone to get sick. Tuberculosis is the world’s thirteenth most significant cause of death, and the second-leading infectious killer after COVID-19, surpassing HIV/AIDS. In 2020, 1.5 million individuals died of tuberculosis, including 214000 HIV-positive people.
Only eight countries account for two-thirds of the world’s TB sufferers. The top seven countries on the list are China, the Philippines, Indonesia, Pakistan, Bangladesh,…
